Keratoconjunctivitis sicca preventing and treating eye drop and preparation and application method thereof

A technology for eye drops and conjunctivitis, applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, and pharmaceutical formulas, etc., can solve problems such as corneal epithelial damage, dependence, temporary treatment but not the root cause, etc., and achieve relief. Evaporation of water, high long-term stability, and the effect of relieving dry eyes

Inactive Publication Date: 2017-07-21
MUDANJIANG MEDICAL UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, clinically, the prevention and treatment of keratitis sicca/conjunctivitis mostly use artificial tears to relieve the clinical symptoms of keratoconjunctivitis sicca, or use steroid hormones or non-steroidal anti-inflammatory drugs locally to relieve ocular surface pain. Inflammation, the above treatment methods can alleviate some clinical symptoms of keratoconjunctivitis sicca to a certain extent, but they can only treat the symptoms but not the root cause, and may even lead to dependence on exogenous eye drops, and the eye drops should be avoided for long-term preservation. Eye infections caused by the application of eye drops often contain preservatives, and long-term use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Keratoconjunctivitis sicca preventing and treating eye drop and preparation and application method thereof
  • Keratoconjunctivitis sicca preventing and treating eye drop and preparation and application method thereof
  • Keratoconjunctivitis sicca preventing and treating eye drop and preparation and application method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1: A kind of eye drop for preventing and treating keratitis sicca / conjunctivitis

[0025] Cyclic alliin 2g;

[0026] Anthocyanin 1g;

[0027] Dextran 70 2g;

[0028] Hydroxypropyl methylcellulose 2g;

[0029] Appropriate amount of potassium chloride and sodium chloride;

[0030] Appropriate amount of pH regulator;

[0031] Add purified water to 1L;

[0032] Prepare as follows:

[0033] (1) each raw material of eye drop is taken by formula quantity for subsequent use;

[0034] (2) Add hydroxypropyl methylcellulose and dextran 70 to purified water, and stir vigorously until completely dissolved;

[0035] (3) adding anthocyanins and alliin to the solution in step (2) and stirring evenly;

[0036] (4) Use potassium chloride and sodium chloride to adjust the solution to be an isotonic solution;

[0037] (5) Use a pH regulator to adjust the pH of the solution to 7.2;

[0038] (6) After the solution is filtered, sterilized by irradiation and filled aseptic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a keratoconjunctivitis sicca preventing and treating eye drop and a preparation and application method thereof. The keratoconjunctivitis sicca preventing and treating eye drop is composed of cyoloalliin, anthocyanin, dextranum, hydroxypropyl methyl cellulose, sodium chloride, potassium chloride, sodium borate, pH regulator and purified water. During application, the keratoconjunctivitis sicca preventing and treating eye drop can supplement water for eyes, form protective films on the surfaces of eyes and reduce water evaporation to effective relieve the symptoms caused by keratoconjunctivitis sicca such as dry eyes, and meanwhile, can stimulate secretion of lacrimal glands and increase the number of times of blinking; the cyoloalliin can inhibit secretion of inflammatory factors to release the clinical symptom of dry eyes and meanwhile fundamentally cure the keratoconjunctivitis sicca; besides, the keratoconjunctivitis sicca preventing and treating eye drop is free from preservatives, safe, non-irritative to eyes, high in long-term stability and applicable to wide application of prevention and treatment of various kinds of keratoconjunctivitis sicca.

Description

technical field [0001] The invention belongs to the field of medicines, and in particular relates to an eye drop for preventing and treating keratitis sicca / conjunctivitis and its preparation method and application. Background technique [0002] Keratoconjunctivitis sicca, also known as dry eye, refers to the abnormal tear quality and quantity or dynamics caused by various reasons, leading to tear film instability and ocular surface tissue lesions, and is characterized by ocular discomfort symptoms It is a general term for a class of diseases, and it is one of the most common eye diseases in today's society. The most common symptoms include dryness, foreign body sensation, and visual fatigue. In severe cases, the eyes will be congested and the corneal epithelium will peel off. Progressive corneal clouding and even blindness develop. There are many factors that cause keratitis sicca / conjunctivitis, mainly including aging, excessive tear evaporation caused by unreasonable use...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/54A61K31/352A61K31/353A61K9/08A61K47/38A61K47/36A61P27/02
CPCA61K9/0048A61K9/08A61K31/352A61K31/353A61K31/54A61K47/36A61K47/38A61K2300/00
Inventor 刘英伟梁绍栋孟祥慧初金玉张万里
Owner MUDANJIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products